查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
避孕器具市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按產品類型、配銷通路、最終用戶、地區細分
市場調查報告書
商品編碼
1321020

避孕器具市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按產品類型、配銷通路、最終用戶、地區細分

Contraceptive Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product Type, By Distribution Channel, By End User, By Region
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計到2027年，全球避孕器具市場將以驚人的速度成長。人們使用避孕器具來避免懷孕和傳染病透過生殖器傳播。市場上的避孕藥具包括避孕帽、組合藥丸、避孕埋植劑、隔膜、陰道環、宮內節育器和避孕套。這些設備是為男性和女性用戶設計和使用的。避孕器具充當物理障礙，阻止精子接觸子宮。因此，它有助於抑制受精並降低感染風險。性傳播疾病流行率的上升和人們對人口過剩控制意識的增強預計將推動避孕器具市場的發展。

性病患病率上升和意識不斷增強推動市場發展

由於日常生活方式的不同，人們面臨著不同的併發症和問題。生活方式包括飲食、睡眠時間、體力活動以及壓力、焦慮和其他問題等心理狀況。 STD（性傳播疾病）是一個重大的全球健康問題。據世界衛生組織統計，平均每25人中就有1人患有性病，可能是一種性病，也可能是同時感染多種性病，這意味著全球有4%的人口患有性病。在分析了這種情況後，人們對性傳播疾病有了更多的認知，並選擇了不同的方法來保證自己的安全。因此，預計未來幾年對避孕器具的需求將會增加。世界各地的國際機構和政府開展不同的宣傳活動並分發避孕器具，以阻止性傳播疾病的傳播並控制人口的快速成長。世界各國政府開展單獨的活動，例如性傳播感染國家戰略計劃，並向從事該領域工作的非政府組織或組織提供資金和贈款，以控制性傳播疾病。這種有利的條件將對避孕器具的成長產生積極影響。

發展中經濟體人口的快速成長是人民和政府的重大關切。印度和中國等國家已經建立了政府組織來幫助不同部門採取預防措施並控制問題。隨著現代化的發展，人們工作繁忙，並開始採取計劃生育來發展事業。據世界衛生組織統計，2019年全球育齡婦女數量為19億；其中，11億人需要計劃生育。因此，為了控制人口，對避孕器具的需求將會增加。此外，高吸收率、可支配收入的增加以及市場參與者的努力是導致預計一年市場上避孕器具需求增加的因素。

與避孕器具相關的健康問題抑制經濟成長

每種藥物在完成劑量或治療後都會對消費者產生副作用。與使用避孕裝置所包括的感染風險增加相同，可能導致不孕。預計這些因素將為避孕器具市場的採用造成障礙。除此之外，缺乏社會接受度以及競爭對手之間的競爭可能會對市場的成長產生負面影響。

加大研發投入

避孕器具市場的擴張推動新產品的推出以及組織之間的深思熟慮的合作夥伴關係。當前的場景將幫助兩個組織利用其能力開發創新產品並增加利潤。除此之外，已開發國家可支配收入的增加預計將推動市場。

市場細分

全球避孕器具市場根據產品類型、配銷通路和最終用戶進行細分。根據產品類型，市場分為避孕套、隔膜、宮頸帽、海綿、陰道環、宮內節育器（IUD）等。根據配銷通路，市場分為醫院藥店、零售藥店、網路藥店等。根據最終用戶，市場按公司分為男性和女性。

市場參與者

Cooper Surgical, Inc., Pfizer, Inc, Merck & Co Inc, AbbVie, Inc, Teva Pharmaceutical Industries Limited, Ansell Ltd, Bayer AG, Mayer Laboratories Inc, Church & Dwight Co Inc, Reckitt Benckiser Group plc是市場營運的主要參與者避孕器具。

可用的客製化

根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。本報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球避孕器具市場的影響

第5章：客戶之聲

第6章：全球避孕器具市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品類型（避孕套、隔膜、宮頸帽、海綿、陰道環、宮內節育器 (IUD) 等）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房、其他）
    • 按最終用戶（男性與女性）
    • 按公司分類 (2021)
    • 按地區
  • 市場地圖

第7章：北美避孕器具市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品類型
    • 按配銷通路
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章：歐洲避孕器具市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品類型
    • 按配銷通路
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太地區避孕器具市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品類型
    • 按配銷通路
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章：南美洲避孕器具市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品類型
    • 按配銷通路
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲避孕器具市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品類型
    • 按配銷通路
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非避孕器具
    • 沙烏地阿拉伯 避孕器具
    • 阿拉伯聯合大公國避孕器具
    • 埃及避孕器具
    • 土耳其避孕器具

第12章：市場動態

  • 促進因素
  • 挑戰

第13章：市場趨勢與發展

第14章：競爭格局

  • Cooper Surgical, Inc.
  • Pfizer, Inc
  • Merck & Co Inc
  • AbbVie, Inc
  • Teva Pharmaceutical Industries Limited
  • Ansell Ltd
  • Bayer AG
  • Mayer Laboratories Inc
  • Church & Dwight Co Inc
  • Reckitt Benckiser Group plc.

第15章：戰略建議

簡介目錄
Product Code: 12871

The global contraceptive devices market is estimated to increase at an impressive rate through 2027. People use contraceptive devices to avoid pregnancy and infectious diseases spread through their genitals. Contraceptives found in the market include caps, combined pills, contraceptive implants, diaphragms, vaginal rings, intrauterine devices, and a condom. These devices are made for and used by both male and female users. Contraceptive devices act as a physical obstacle preventing sperm from contacting a uterus. Thereby, it helps in restraining insemination and reducing the risk of infection. The rising prevalence of STDs and growing awareness of people's overpopulation control is expected to drive the market for contraceptive devices.

Furthermore, an increase in government initiatives, marketing efforts by the market players, and a rise in disposable income are other factors that are expected to appreciably influence the market's progress through 2027. In 2020, The fertility rate in the United States Fertility Rate was 1.78 per person. The above data shows that people are quite serious about family planning and take precautions to avoid pregnancy. Thus, the United States Contraception market is going to experience growth in the projected year due to their awareness and increasing population.

Rising Prevalence of STDs and Growing Awareness is Propelling the Market

People are facing different complications and problems due to variations in their daily lifestyles. Lifestyle involves diet, sleeping hours, physical activities, and psychological conditions like stress, anxiety, and other problems. STDs (sexually transmitted diseases) are a significant global health issue. According to the WHO, on average, 1 out of 25 people face STDs, which may be one STI or multiple infections at the same time, which means 4% of the global population is suffering from STDs. After analyzing the scenario, people are more aware of the STDs and opt for different methods the keep themselves safe. As a result, the demand for contraceptive devices is expected to swell in the forthcoming years. International agencies and governments worldwide are running different awareness campaigns and distributing contraceptive devices to stop STDs from spreading and controlling the rapid boost of the population. Various governments of the world are running separate campaigns, such as STI National Strategic Plan, and providing funds and grants to NGOs or organizations working in this sector to take control over STDs. This favorable condition is going to impact the growth of contraceptive devices positively.

The rapidly growing population of developing economies is a significant concern for the people as well as the government. Countries like India and China have established government organizations to help the different ministry to take preventive measures and control the problem. Due to modernization, people are busy with their work and are adopting family planning for career building. According to WHO, in 2019, there were 1.9 billion women of reproductive age group globally; out of them, 1.1 billion needed family planning. Thus, the demand for contraceptive devices is going to increase for population control. Additionally, the high absorption rate, rise in disposable income, and effort by the market player are the factor that led to increasing demand for contraceptive devices in the market for a projected year.

Health Issue Associated with Contraceptive Devices is Restraining Growth

Every medicine has side effects on the consumer after completing the dose or treatment. Same as the increased risk of infection involved in the use of a contraceptive device which could lead to infertility. These factors are expected to create hurdles in the adoption of the contraceptive devices market. Apart from these, the lack of social acceptance and competition between the rivals to make the alternative can negatively influence the growth of the market.

Increase in Research and Development Investment

Expansion in the contraceptive devices market is driving the launch of new products and deliberate partnerships among the organizations. The current scenarios will help both organizations to use their competencies to develop innovative products and increase profits. Apart from these, rising disposable income around developed countries is expected to propel the market.

Market Segmentation

The global contraceptive devices market is segmented based on product type, distribution channel, and end user. Based on product type, the market is divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUDs), and others. Based on distribution channels, the market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end users, the market is split into male and female, by company.

Market Players

Cooper Surgical, Inc., Pfizer, Inc, Merck & Co Inc, AbbVie, Inc, Teva Pharmaceutical Industries Limited, Ansell Ltd, Bayer AG, Mayer Laboratories Inc, Church & Dwight Co Inc, Reckitt Benckiser Group plc are the major player operating in the contraceptive devices Market.

Report Scope

In this report, global Contraceptive Devices Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Contraceptive Devices Market, By Product Type:

  • Condoms
  • Diaphragms
  • Cervical Caps Sponges
  • Vaginal Rings
  • Intra Uterine Devices (IUDs)
  • Others

Contraceptive Devices Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Contraceptive Devices Market, By End User:

  • Male
  • Female

Medical market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Contraceptive Devices Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Contraceptive Devices Market

5. Voice of Customer

6. Global Contraceptive Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), Others)
    • 6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
    • 6.2.3. By End User (Male v/s Female)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America Contraceptive Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Contraceptive Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Distribution Channel
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico Contraceptive Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Distribution Channel
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada Contraceptive Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Distribution Channel
        • 7.3.3.2.3. By End User

8. Europe Contraceptive Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Contraceptive Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Distribution Channel
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Contraceptive Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Distribution Channel
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Contraceptive Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Distribution Channel
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Contraceptive Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Distribution Channel
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Contraceptive Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Distribution Channel
        • 8.3.5.2.3. By End User

9. Asia-Pacific Contraceptive Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Contraceptive Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Distribution Channel
        • 9.3.1.2.3. By End User
    • 9.3.2. India Contraceptive Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Distribution Channel
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Contraceptive Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Distribution Channel
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Contraceptive Devices Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product Type
        • 9.3.4.2.2. By Distribution Channel
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Contraceptive Devices Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product Type
        • 9.3.5.2.2. By Distribution Channel
        • 9.3.5.2.3. By End User

10. South America Contraceptive Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Contraceptive Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Distribution Channel
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Contraceptive Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Distribution Channel
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Contraceptive Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Distribution Channel
        • 10.3.3.2.3. By End User

11. Middle East and Africa Contraceptive Devices Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Distribution Channel
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Contraceptive Devices Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Distribution Channel
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Contraceptive Devices Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Distribution Channel
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Contraceptive Devices Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Distribution Channel
        • 11.3.3.2.3. By End User
    • 11.3.4. Egypt Contraceptive Devices Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product Type
        • 11.3.4.2.2. By Distribution Channel
        • 11.3.4.2.3. By End User
    • 11.3.5. Turkey Contraceptive Devices Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product Type
        • 11.3.5.2.2. By Distribution Channel
        • 11.3.5.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Cooper Surgical, Inc.
  • 14.2. Pfizer, Inc
  • 14.3. Merck & Co Inc
  • 14.4. AbbVie, Inc
  • 14.5. Teva Pharmaceutical Industries Limited
  • 14.6. Ansell Ltd
  • 14.7. Bayer AG
  • 14.8. Mayer Laboratories Inc
  • 14.9. Church & Dwight Co Inc
  • 14.10. Reckitt Benckiser Group plc.

15. Strategic Recommendations